Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page
- Check4 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.7%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference16%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has removed the previous version of the treatment for steroid-refractory acute graft-versus-host disease and replaced it with a new version dated August 13, 2025.SummaryDifference2%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.